Sponsorship

BMJ Masterclass sponsored symposia

BMJ Masterclasses are a series of face to face educational events run by BMJ to help doctors make better decisions. In order to produce quality events we work with appropriate sponsors, including pharmaceutical companies, who share our principles and want to help provide doctors with high quality education. We work with sponsors under the principles of transparency, probity, and editorial independence.

BMJ Masterclasses may contain a sponsored, non-promotional symposium (the “sponsored symposium”). The content of the sponsored symposium must be relevant to the specified masterclass, pitched to the appropriate target audience, non-promotional, evidence based, and of educational value to delegates. The topic of the symposium needs to be a common and important symptom or disease entity. The presentation should be comprehensive. It may cover diagnosis, prevention, or management. It should cover all relevant options within these entities (for example it could cover only management but if so it should cover non-drug management, drug management, and surgical options). Studies may be presented, but this mustn't take up the majority of the content of the presentation. Drugs must not be referred to by their brand names within the presentation slides.

Where a topic is suggested by a sponsor, the BMJ Masterclasses editorial team decides whether this is an area of educational value for potential delegates. The sponsor should nominate a speaker who has the ability to deliver good, relevant content, transparency in any commercial dealings, and authority in their field. The BMJ Masterclass editorial team reserves the right to refuse a speaker who does not meet the criteria listed above. The BMJ Masterclass editorial team reserves the right to refuse a topic suggestion if not felt to be of educational relevance to our intended audience. The speaker must be responsible for producing the slides for the presentation. The BMJ Masterclass editorial team reserves the right to request alterations or refuse content. The speaker must introduce their talk with a verbal and visual "Declaration of interests," as outlined in the speaker guidelines. As part of this, they should state that they have been invited to present the symposium on behalf of the sponsor and should acknowledge any support they have received from the sponsor.

Delegates are invited to attend the sponsored symposium; however, attendance at the symposium is optional.

For sponsorship opportunities please contact:

Simon Walker
Senior Sales Manager
swalker@bmj.com
020 7383 6350

David Bell
Sales Manager
dbell@bmj.com
020 7383 6053

Laura Stanley
Event Sales Support Executive
lstanley@bmj.com
020 7383 6181

2013 Symposium Sponsors

Bayer
Boeheringer Ingleheim & Lilly Alliance
Chugai Pharma UK Ltd and Roche Products Limited
Eisai
Flynn Pharma Limited
Intermune UK and Ireland Limited
Janssen
Lilly UK
The MDU
Pfizer
Pfizer and Bristol Myers Squibb

2013 Exhibitors

Almirall
Bayer
Boehringer Ingelheim
Borheringer Ingleheim & Lilly Alliance
Bristol Myers Squibb and AstraZeneca
Chiesi Limited
Chugai Pharma UK Ltd and Roche Products Limited
Danone
Dermal Laboratories
Eisai
Flynn Pharma Limited
Genus
GlaxoSmithKline UK Limited
Head Medical
Intermune UK and Ireland Limited
Janssen
Lilly UK
The MDU
Moorfields Pharmaceuticals
Meda
Merck Sharpe and Dohme Limited
Merck Serono
Ossur
Pfizer
Pfizer and Bristol Myers Squibb
Servier Laboratories
Shire Pharmaceuticals Limited
Target Ovarian Cancer
Wesleyan Assurance Society